Trial Details

TERMINATED
Basic Information
Clinical ID c520
Identifier NCT01061996
Trial Title Basiliximab Maintenance in Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Basiliximab
Participant Information
Sponsor Cerimon Pharmaceuticals
City Bristol
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2025-07-07
Primary Completion Date 2025-12-08
Completion Date 2025-12-08